Trading Report: Today, Humana’s (HUM) Neutral Rating Reiterated at Susquehanna

Today, Humana’s (HUM) Neutral Rating Reiterated at Susquehanna

Susquehanna restated their neutral rating on shares of Humana Inc. (NYSE:HUM) in a report issued on Thursday. Susquehanna currently has a $180.00 price target on the insurance provider’s stock.

Several other equities research analysts have also recently issued reports on HUM. Cantor Fitzgerald reaffirmed a buy rating on shares of Humana in a research note on Saturday, July 9th. RBC Capital Markets reaffirmed a buy rating and set a $224.00 target price (up previously from $220.00) on shares of Humana in a research note on Friday, July 22nd. Jefferies Group lowered their target price on shares of Humana from $220.00 to $217.00 and set a buy rating on the stock in a research note on Thursday, August 4th. Royal Bank Of Canada lowered their target price on shares of Humana from $222.00 to $217.00 and set a sector perform rating on the stock in a research note on Thursday, October 13th. Finally, Barclays PLC lowered their target price on shares of Humana from $193.00 to $191.00 and set an equal weight rating on the stock in a research note on Thursday, August 4th. Seven research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. The company has a consensus rating of Buy and an average target price of $200.50.

Humana (NYSE:HUM) opened at 169.89 on Thursday. The stock has a market cap of $25.32 billion, a P/E ratio of 26.10 and a beta of 0.90. The company has a 50-day moving average of $175.73 and a 200 day moving average of $175.51. Humana has a 1-year low of $150.00 and a 1-year high of $191.65.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The firm had revenue of $14 billion for the quarter, compared to analysts’ expectations of $13.59 billion. During the same quarter last year, the company earned $1.67 EPS. The firm’s revenue for the quarter was up 2.0% compared to the same quarter last year. Analysts predict that Humana will post $9.24 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Thursday, October 13th will be paid a dividend of $0.29 per share. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.16 dividend on an annualized basis and a yield of 0.68%. Humana’s dividend payout ratio (DPR) is presently 18.18%.

Hedge funds have recently modified their holdings of the company. Point72 Asia Hong Kong Ltd acquired a new stake in shares of Humana during the second quarter worth about $126,000. Daiwa SB Investments Ltd. increased its position in shares of Humana by 1.4% in the third quarter. Daiwa SB Investments Ltd. now owns 730 shares of the insurance provider’s stock worth $129,000 after buying an additional 10 shares in the last quarter. Bessemer Group Inc. increased its position in shares of Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock worth $183,000 after buying an additional 797 shares in the last quarter. Fulton Bank N.A. bought a new position in shares of Humana during the third quarter worth approximately $229,000. Finally, BB&T Securities LLC increased its position in shares of Humana by 13.6% in the second quarter. BB&T Securities LLC now owns 1,374 shares of the insurance provider’s stock worth $247,000 after buying an additional 165 shares in the last quarter. Institutional investors own 93.27% of the company’s stock.

Humana Company Profile

Related posts

Leave a Comment